Diabetic Therapy Market - Trends Forecast Till 2028

Diabetic Therapy Market by Product [Injectables (Insulin, Glucagon-like Peptide-1 (GLP-1) Receptor Agonists, and Amylinomimetic Drugs) and Oral-antidiabetic Drugs (OAD) (Biguanides, Sulfonylureas, Thiazolidinediones, Alpha-glucosidase Inhibitors, Dipeptidyl Peptidase IV (DPP-4) Inhibitors, Meglitinides, and Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors)], and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: January, 2022

Base Year Estimate: 2021

Report ID: D-PH-DTM-1117


Number of Pages: 397

Domain: Pharmaceutical

Diabetic Therapy Market – Trends Forecast Till 2028

The Diabetic Therapy market size is projected to reach a CAGR of 17% from 2022 to 2028.

Diabetes is a medical condition that arise due to the inability of the body to contain and alter the blood sugar levels as per the needs. This occurs either due to decreased secretion of insulin by the pancreas or could also occur due to the genetic disorder. The major therapy used for the treatment is gene therapy.

Increased incidents of diabetes along with the recent development in the sector are some of the factors that have supported long-term expansion for Diabetic Therapy Market.

Diabetic Therapy Market Research Report

North America is the most rapidly growing market and offers a huge opportunity for the automotive industry, whose growth is driven by the increased investments in the sector and also the favourable governmental policies.

Diabetic Therapy Market is segmented into product and region.

On the basis of Product

  • Injectables
    • Insulin
    • Glucagon-like Peptide-1 (GLP-1) Receptor Agonists/Incretin
    • Amylinomimetic Drugs
  • Oral-antidiabetic Drugs (OAD)
    • Biguanides
    • Sulfonylureas
    • Thiazolidinediones
    • Alpha-glucosidase Inhibitors
    • Dipeptidyl Peptidase IV (DPP-4) Inhibitors/Gliptins
    • Meglitinides
    • Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors/Gliflozins              

On the basis of Region

  • Asia Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa

Insights are provided for each region and major countries within the regions

Diabetic Therapy Market Primary Respondent


Key Players

  • Astrazeneca plc
  • Boehringer ingelheim gmbh
  • Eli lilly and company
  • Glaxosmithkline plc
  • Johnson & johnson
  • Merck & co., inc.
  • Novartis ag
  • Novo nordisk
  • Sanofi s.a.
  • Takeda pharmaceutical company limited

Recent Developments

  • In December 2020, AstraZeneca completed the acquisition of Alexion with an aim of moving further in the sector of immunology.

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
  • Gain authentic and granular data access for Diabetic Therapy Market so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope


Report Feature


Growth Rate

CAGR of 17% during the forecasting period, 2022-2028

Historical Data


Forecast Years


Base Year


Units Considered

Revenue in USD billion and CAGR from 2022 to 2028

Report Segmentation

Product and region.

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

AstraZeneca plc, Boehringer Ingelheim GmbH, Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Novo Nordisk, Sanofi S.A., and Takeda Pharmaceutical Company Limited

Available Customization

In addition to the market data for Diabetic Therapy Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.

Regional Report

Note: Report data and information will be by Country.

Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.